Patent ID: 6630478
Filing Date: 2003-10-07
Classification: A61K,A61P,C07D,Y02A

Abstract:
A method of treating drug-induced neuropathy comprising administering to a patient with drug-induced neuropathy in effective amount of N-4-carboxyphenyl-3-(6-oxohydropurin-9-yl) propanamide, also known as AIT-082, wherein said neuropathy is induced by an oncolytic drug selected from the group consisting of a vinca alkaloid, cisplatin, paclitaxel, suramin, altretamine, carboplatin, chlorambucil, cytarabine, dacarbazine, docetaxel, etoposide, fludarabine, ifosfamide with mesna, tamoxifen, teniposide, and thioguanine.